| Identification | Back Directory | [Name]
1,3-Benzodioxole-5-carboxamide, 7-chloro-N-[[1,2-dihydro-6-methyl-4-(methylthio)-2-oxo-3-pyridinyl]methyl]-2-[4-(3-methoxy-1-azetidinyl)cyclohexyl]-2,4-dimethyl- | [CAS]
2387402-80-2 | [Synonyms]
EZH2-IN-11
1,3-Benzodioxole-5-carboxamide, 7-chloro-N-[[1,2-dihydro-6-methyl-4-(methylthio)-2-oxo-3-pyridinyl]methyl]-2-[4-(3-methoxy-1-azetidinyl)cyclohexyl]-2,4-dimethyl- | [Molecular Formula]
C28H36ClN3O5S | [MOL File]
2387402-80-2.mol | [Molecular Weight]
562.12 |
| Hazard Information | Back Directory | [Uses]
EZH2-IN-11 is a potent inhibitor of E2HZ. The oncogenic activities of EZH2 have been shown by a number of studies in various different cancer types. EZH2-IN-11 has the potential for the research of cancer diseases (extracted from patent WO2019204490A1, compound 17)[1]. | [References]
[1] Alexandre C?té, et al. Modulators of methyl modifying enzymes, compositions and uses thereof. Patent WO2019204490A1. |
|
|